The association between antenatal SARS-CoV-2 exposure and infant neurodevelopment at four months of age: A prospective multicenter cohort survey within the COPE study

Objectives: It remains unclear whether antenatal SARS-CoV-2 exposure affects subsequent infant neurodevelopment. We aimed to investigate the association between antenatal maternal SARS-CoV-2 infection and neurodevelopment in four-month-old infants. Methods: Data was collected within the prospective...

Full description

Saved in:
Bibliographic Details
Main Authors: Johan Berg, Karolina Linden, Mehreen Zaigham, Magnus Domellöf, Fredrik Ahlsson, Anders Elfvin, Ulrika Åden, Thomas Abrahamsson, Andreas Ohlin, Johannna Berg, Linda Hjertberg, Sofie Graner, Sophia Brismar Wendel, Linda Iorizzo, Sofie Arnkil, Ylva Carlsson, Malin Veje, Lina Bergman, Verena Sengpiel, Ola Andersson
Format: Article
Language:English
Published: Elsevier 2025-09-01
Series:International Journal of Infectious Diseases
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971225001973
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839582715830075392
author Johan Berg
Karolina Linden
Mehreen Zaigham
Magnus Domellöf
Fredrik Ahlsson
Anders Elfvin
Ulrika Åden
Thomas Abrahamsson
Andreas Ohlin
Johannna Berg
Linda Hjertberg
Sofie Graner
Sophia Brismar Wendel
Linda Iorizzo
Sofie Arnkil
Ylva Carlsson
Malin Veje
Lina Bergman
Verena Sengpiel
Ola Andersson
author_facet Johan Berg
Karolina Linden
Mehreen Zaigham
Magnus Domellöf
Fredrik Ahlsson
Anders Elfvin
Ulrika Åden
Thomas Abrahamsson
Andreas Ohlin
Johannna Berg
Linda Hjertberg
Sofie Graner
Sophia Brismar Wendel
Linda Iorizzo
Sofie Arnkil
Ylva Carlsson
Malin Veje
Lina Bergman
Verena Sengpiel
Ola Andersson
author_sort Johan Berg
collection DOAJ
description Objectives: It remains unclear whether antenatal SARS-CoV-2 exposure affects subsequent infant neurodevelopment. We aimed to investigate the association between antenatal maternal SARS-CoV-2 infection and neurodevelopment in four-month-old infants. Methods: Data was collected within the prospective multicenter COVID-19 during pregnancy and early childhood study, COPE (NCT04433364). Infants exposed to maternal SARS-CoV-2 infection from conception until two days postpartum and unexposed controls were included June 2020-December 2022. Primary outcome: four-month-old infant neurodevelopment, measured using the Ages and Stages Questionnaire 3rd Edition (ASQ) total mean scores. Secondary outcomes: Scores below cutoff for total ASQ or the ASQ domains. Results: Of 2453 enrolled infants, 1446 (555 exposed and 891 unexposed) had available ASQ data. In adjusted regression models, there was no group difference in ASQ total mean scores. Exposed infants had lower risk of fine motor domain scores below cutoff (exposed: 4.0% vs. unexposed: 6.6%; adjusted odds ratio (aOR), 0.55; 95% CI, 0.33-0.92). Infants exposed to severe maternal COVID-19 had increased risk of total ASQ scores below cutoff (exposed: 16.0% vs. unexposed: 6.1%; aOR, 3.57; 95% CI, 1.14-11.24). Conclusions: Antenatal maternal SARS-CoV-2 infection was not associated with overall impaired four-month infant neurodevelopmental screening. In exploratory analyses, severe maternal COVID-19 was associated with abnormal screening results.
format Article
id doaj-art-9d4fa0986daa45da943f87c41e93f95a
institution Matheson Library
issn 1201-9712
language English
publishDate 2025-09-01
publisher Elsevier
record_format Article
series International Journal of Infectious Diseases
spelling doaj-art-9d4fa0986daa45da943f87c41e93f95a2025-08-04T04:23:55ZengElsevierInternational Journal of Infectious Diseases1201-97122025-09-01158107973The association between antenatal SARS-CoV-2 exposure and infant neurodevelopment at four months of age: A prospective multicenter cohort survey within the COPE studyJohan Berg0Karolina Linden1Mehreen Zaigham2Magnus Domellöf3Fredrik Ahlsson4Anders Elfvin5Ulrika Åden6Thomas Abrahamsson7Andreas Ohlin8Johannna Berg9Linda Hjertberg10Sofie Graner11Sophia Brismar Wendel12Linda Iorizzo13Sofie Arnkil14Ylva Carlsson15Malin Veje16Lina Bergman17Verena Sengpiel18Ola Andersson19Department of Neonatology, Skåne University Hospital, Malmö/Lund, Sweden; Department of Clinical Sciences Lund, Pediatrics, Lund University, Lund, Sweden; Corresponding author. Johan Berg, Department of Neonatology and Child Surgery, Skåne University Hospital, Klinikgatan, 12, 221 85 Lund, Sweden.Sahlgrenska Academy, Institute of Health and Care Sciences, University of Gothenburg, Gothenburg, SwedenDepartment of Clinical Sciences Malmö, Obstetrics and Gynaecology, Lund University and Skåne University Hospital, Malmö, SwedenDepartment of Clinical Sciences, Pediatrics, Umeå University, Umeå, SwedenDepartment of Women´s and Children’s Health, Uppsala University, Uppsala, SwedenDepartment of Pediatrics, Institution of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Region Västra Götaland, Department of Pediatrics, The Queen Silvia Children’s Hospital, Sahlgrenska University Hospital, Gothenburg, SwedenDepartment of Women’s and Children’s Health, Karolinska Institutet, Solna, Sweden; Neonatal Unit, Karolinska University Hospital, Solna, SwedenDepartment of Biomedical and Clinical Sciences, Linköping University and Crown Princess Victoria Children’s Hospital, Linköping, SwedenDepartment of Pediatrics, Faculty of Medicine and Health, Örebro University, Örebro, SwedenDepartment of Obstetrics and Gynaecology, Institute of Clinical Science, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Region Västra Götaland, Department of Obstetrics and Gynaecology, NU Hospital Group, Trollhättan, SwedenDepartment of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden; Department of Obstetrics and Gynecology, Vrinnevihospital, Norrköping, SwedenCentre for Pharmacoepidemiology, Department of Medicine, Karolinska Institutet, Solna, SwedenDepartment of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, SwedenDepartment of Clinical Sciences Lund, Obstetrics and Gynaecology, Lund University and Skåne University Hospital, Lund, SwedenDepartment of Obstetrics and Gynaecology, Institute of Clinical Science, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenDepartment of Obstetrics and Gynaecology, Institute of Clinical Science, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Region Västra Götaland, Sahlgrenska University Hospital, Department of Obstetrics and Gynaecology, Gothenburg, SwedenDepartment of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Infectious Diseases, Sahlgrenska University Hospital, Gothenburg, SwedenDepartment of Obstetrics and Gynaecology, Institute of Clinical Science, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Region Västra Götaland, Sahlgrenska University Hospital, Department of Obstetrics and Gynaecology, Gothenburg, SwedenDepartment of Obstetrics and Gynaecology, Institute of Clinical Science, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Region Västra Götaland, Sahlgrenska University Hospital, Department of Obstetrics and Gynaecology, Gothenburg, SwedenDepartment of Neonatology, Skåne University Hospital, Malmö/Lund, Sweden; Department of Clinical Sciences Lund, Pediatrics, Lund University, Lund, SwedenObjectives: It remains unclear whether antenatal SARS-CoV-2 exposure affects subsequent infant neurodevelopment. We aimed to investigate the association between antenatal maternal SARS-CoV-2 infection and neurodevelopment in four-month-old infants. Methods: Data was collected within the prospective multicenter COVID-19 during pregnancy and early childhood study, COPE (NCT04433364). Infants exposed to maternal SARS-CoV-2 infection from conception until two days postpartum and unexposed controls were included June 2020-December 2022. Primary outcome: four-month-old infant neurodevelopment, measured using the Ages and Stages Questionnaire 3rd Edition (ASQ) total mean scores. Secondary outcomes: Scores below cutoff for total ASQ or the ASQ domains. Results: Of 2453 enrolled infants, 1446 (555 exposed and 891 unexposed) had available ASQ data. In adjusted regression models, there was no group difference in ASQ total mean scores. Exposed infants had lower risk of fine motor domain scores below cutoff (exposed: 4.0% vs. unexposed: 6.6%; adjusted odds ratio (aOR), 0.55; 95% CI, 0.33-0.92). Infants exposed to severe maternal COVID-19 had increased risk of total ASQ scores below cutoff (exposed: 16.0% vs. unexposed: 6.1%; aOR, 3.57; 95% CI, 1.14-11.24). Conclusions: Antenatal maternal SARS-CoV-2 infection was not associated with overall impaired four-month infant neurodevelopmental screening. In exploratory analyses, severe maternal COVID-19 was associated with abnormal screening results.http://www.sciencedirect.com/science/article/pii/S1201971225001973Child developmentNeurodevelopmental disordersSARS-CoV-2InfantPregnancy complications, InfectiousPrenatal exposure delayed effects
spellingShingle Johan Berg
Karolina Linden
Mehreen Zaigham
Magnus Domellöf
Fredrik Ahlsson
Anders Elfvin
Ulrika Åden
Thomas Abrahamsson
Andreas Ohlin
Johannna Berg
Linda Hjertberg
Sofie Graner
Sophia Brismar Wendel
Linda Iorizzo
Sofie Arnkil
Ylva Carlsson
Malin Veje
Lina Bergman
Verena Sengpiel
Ola Andersson
The association between antenatal SARS-CoV-2 exposure and infant neurodevelopment at four months of age: A prospective multicenter cohort survey within the COPE study
International Journal of Infectious Diseases
Child development
Neurodevelopmental disorders
SARS-CoV-2
Infant
Pregnancy complications, Infectious
Prenatal exposure delayed effects
title The association between antenatal SARS-CoV-2 exposure and infant neurodevelopment at four months of age: A prospective multicenter cohort survey within the COPE study
title_full The association between antenatal SARS-CoV-2 exposure and infant neurodevelopment at four months of age: A prospective multicenter cohort survey within the COPE study
title_fullStr The association between antenatal SARS-CoV-2 exposure and infant neurodevelopment at four months of age: A prospective multicenter cohort survey within the COPE study
title_full_unstemmed The association between antenatal SARS-CoV-2 exposure and infant neurodevelopment at four months of age: A prospective multicenter cohort survey within the COPE study
title_short The association between antenatal SARS-CoV-2 exposure and infant neurodevelopment at four months of age: A prospective multicenter cohort survey within the COPE study
title_sort association between antenatal sars cov 2 exposure and infant neurodevelopment at four months of age a prospective multicenter cohort survey within the cope study
topic Child development
Neurodevelopmental disorders
SARS-CoV-2
Infant
Pregnancy complications, Infectious
Prenatal exposure delayed effects
url http://www.sciencedirect.com/science/article/pii/S1201971225001973
work_keys_str_mv AT johanberg theassociationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT karolinalinden theassociationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT mehreenzaigham theassociationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT magnusdomellof theassociationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT fredrikahlsson theassociationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT anderselfvin theassociationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT ulrikaaden theassociationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT thomasabrahamsson theassociationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT andreasohlin theassociationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT johannnaberg theassociationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT lindahjertberg theassociationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT sofiegraner theassociationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT sophiabrismarwendel theassociationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT lindaiorizzo theassociationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT sofiearnkil theassociationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT ylvacarlsson theassociationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT malinveje theassociationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT linabergman theassociationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT verenasengpiel theassociationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT olaandersson theassociationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT johanberg associationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT karolinalinden associationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT mehreenzaigham associationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT magnusdomellof associationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT fredrikahlsson associationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT anderselfvin associationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT ulrikaaden associationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT thomasabrahamsson associationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT andreasohlin associationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT johannnaberg associationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT lindahjertberg associationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT sofiegraner associationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT sophiabrismarwendel associationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT lindaiorizzo associationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT sofiearnkil associationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT ylvacarlsson associationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT malinveje associationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT linabergman associationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT verenasengpiel associationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy
AT olaandersson associationbetweenantenatalsarscov2exposureandinfantneurodevelopmentatfourmonthsofageaprospectivemulticentercohortsurveywithinthecopestudy